Effets du cytom??galovirus en transplantation et place de la prophylaxie antivirale, N??phrologie & Th??rapeutique, vol.6, issue.6, pp.505-512, 2010. ,
DOI : 10.1016/j.nephro.2010.06.003
The pathogenesis and clinical management of cytomegalovirus infection in the organ transplant recipient: the end of the ???silo hypothesis???, Current Opinion in Infectious Diseases, vol.20, issue.4, pp.399-407, 2007. ,
DOI : 10.1097/QCO.0b013e328285a358
High Incidence of Ganciclovir???Resistant Cytomegalovirus Infection among Lung Transplant Recipients Receiving Preemptive Therapy, The Journal of Infectious Diseases, vol.185, issue.1, pp.20-27, 2002. ,
DOI : 10.1086/338143
New Strategies for Prevention and Therapy of Cytomegalovirus Infection and Disease in Solid-Organ Transplant Recipients, Clinical Microbiology Reviews, vol.13, issue.1, pp.83-121, 2000. ,
DOI : 10.1128/CMR.13.1.83-121.2000
Infection in organ-transplant recipie n t s . N E n g l J M e, 1998. ,
Quantitative Analysis of Cytomegalovirus Viremia in Lung Transplant Recipients, Journal of Infectious Diseases, vol.171, issue.4, pp.1006-1010, 1995. ,
DOI : 10.1093/infdis/171.4.1006
Acyclovir chemistry and spectrum of activity, The American Journal of Medicine, vol.73, issue.1, pp.4-6, 1982. ,
DOI : 10.1016/0002-9343(82)90054-7
,3-Dihydroxy-2-propoxy)methyl]guanine: a new potent and selective antiherpes agent, J Med Chem, vol.91, issue.26, pp.759-761, 1983. ,
A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells, Nature, vol.358, issue.6382, 1992. ,
DOI : 10.1038/358162a0
Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir, Nature, vol.358, issue.6382, pp.160-162, 1992. ,
DOI : 10.1038/358160a0
Metabolic activation of the nucleoside analog 9-[( 2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine in human diploid fibroblasts infected with human cytomegalovirus., Proceedings of the National Academy of Sciences, vol.82, issue.8, pp.2473-2477, 1985. ,
DOI : 10.1073/pnas.82.8.2473
A randomized prospective controlled trial of oral acyclovir versus oral ganciclovir for cytomegalovirus prophylaxis in high-risk kidney transplant recipients, Transplantation, vol.66, pp.3053-3055, 1998. ,
Randomised comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipients, The Lancet, vol.346, issue.8967, pp.69-74, 1995. ,
DOI : 10.1016/S0140-6736(95)92110-9
Effets du cytom??galovirus en transplantation et place de la prophylaxie antivirale, N??phrologie & Th??rapeutique, vol.6, issue.6, pp.505-512, 2010. ,
DOI : 10.1016/j.nephro.2010.06.003
Cytomegalovirus risk factors in renal transplantation with modern immunosuppression, Transplant Infectious Disease, vol.55, issue.(4, pp.480-488, 2010. ,
DOI : 10.1111/j.1399-3062.2010.00533.x
Antivirals and antiviral strategies, Nature Reviews Microbiology, vol.62, issue.9, pp.704-720, 2004. ,
DOI : 10.1073/pnas.2234683100
Pharmacodynamics of Oral Ganciclovir and Valganciclovir in Solid Organ Transplant Recipients, Transplantation, vol.79, issue.11, pp.1477-1483, 2005. ,
DOI : 10.1097/01.TP.0000164512.99703.AD
Latent Infection and the Elusive Cytomegalovirus, Clinical Infectious Diseases, vol.5, issue.2, pp.205-215, 1983. ,
DOI : 10.1093/clinids/5.2.205
Lysis of Cytomegalovirus-lnfected Human Fibroblasts and Transformed Human Cells by Peripheral Blood Lymphoid Cells from Normal Human Donors, Experimental Biology and Medicine, vol.154, issue.2, pp.259-263, 1977. ,
DOI : 10.3181/00379727-154-39650
History of the Cytomegalovirus, Southern Medical Journal, vol.90, issue.2, pp.184-190, 1997. ,
DOI : 10.1097/00007611-199702000-00004
The DNA sequence of the human cytomegalovirus genome, DNA Sequence, vol.1, issue.1, pp.1-12, 1991. ,
DOI : 10.1016/0042-6822(90)90294-2
Analysis of the Protein-Coding Content of the Sequence of Human Cytomegalovirus Strain AD169, Curr Top Microbiol Immunol, vol.154, pp.125-169, 1990. ,
DOI : 10.1007/978-3-642-74980-3_6
Cytopathogenic agent resembling human salivary gland virus recovered from tissue cultures of human adenoids, Proc Soc Exp Biol Med Soc Exp Biol Med N Y N, vol.92, pp.418-424, 1956. ,
Genetic content of wild-type human cytomegalovirus, Journal of General Virology, vol.85, issue.5, pp.1301-1312, 2004. ,
DOI : 10.1099/vir.0.79888-0
Genomic and Functional Characteristics of Human Cytomegalovirus Revealed by Next-Generation Sequencing, Viruses, vol.6, issue.3, pp.1049-1072, 2014. ,
DOI : 10.3390/v6031049
Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir, Nature, vol.358, issue.6382, pp.160-162, 1992. ,
DOI : 10.1038/358160a0
Betaherpes viral genes and their functions, Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis, 2007. ,
Coiled-Coil Domains in Glycoproteins B and H Are Involved in Human Cytomegalovirus Membrane Fusion, Journal of Virology, vol.78, issue.15, pp.8333-8341, 2004. ,
DOI : 10.1128/JVI.78.15.8333-8341.2004
The Role of the Cytoskeleton During Viral Infection, Curr Top Microbiol Immunol, vol.285, pp.67-108, 2005. ,
DOI : 10.1007/3-540-26764-6_3
Human cytomegalovirus immediate-early over protein 2 (IE2)-mediated activation of cyclin E is cell-cycle-independent and forces S-phase entry in IE2-arrested cells, Journal of General Virology, vol.84, issue.1, pp.51-60, 2003. ,
DOI : 10.1099/vir.0.18702-0
A human cytomegalovirus antagonist of type I IFN-dependent signal transducer and activator of transcription signaling, Proceedings of the National Academy of Sciences, vol.103, issue.10, pp.3840-3845, 2006. ,
DOI : 10.1073/pnas.0600007103
Dissecting human cytomegalovirus gene function and capsid maturation by ribozyme targeting and electron cryomicroscopy, Proceedings of the National Academy of Sciences, vol.102, issue.20, pp.7103-7111, 2005. ,
DOI : 10.1073/pnas.0408826102
Herpesvirus assembly: An update, Virus Research, vol.143, issue.2, pp.222-256, 2009. ,
DOI : 10.1016/j.virusres.2009.03.018
Inapparent Congenital Cytomegalovirus Infection, New England Journal of Medicine, vol.288, issue.26, pp.1370-1372, 1973. ,
DOI : 10.1056/NEJM197306282882603
Cytomegalovirus Viral infections of humans: epidemiology and control, pp.143-161, 1976. ,
Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome, JAMA: The Journal of the American Medical Association, vol.256, issue.14, pp.1904-1912, 1986. ,
DOI : 10.1001/jama.256.14.1904
Congenital and maternal cytomegalovirus infections in a London population, BJOG: An International Journal of Obstetrics and Gynaecology, vol.158, issue.2, pp.135-140, 1991. ,
DOI : 10.1001/jama.256.14.1904
Neonatal screening for congenital cytomegalovirus infections, Journal of Perinatal Medicine, vol.27, issue.2, pp.116-121, 1999. ,
DOI : 10.1515/JPM.1999.015
Congenital cytomegalovirus infection in a northern Italian region. NEOCMV Group, European Journal of Epidemiology, vol.14, issue.8, pp.791-796, 1998. ,
DOI : 10.1023/A:1007554726449
Progressive hearing loss in infants with asymptomatic congenital cytomegalovirus infection, Pediatrics, vol.90, pp.862-866, 1992. ,
Cytomegalovirus-related childhood mortality in Australia, 1999. ,
Clinical and Immunologic Aspects of Cytomegalovirus Infection in Solid Organ Transplant Recipients, Transplantation, vol.79, issue.4, pp.381-387, 2005. ,
DOI : 10.1097/01.TP.0000148239.00384.F0
Cytomegalovirus in transplantation ? challenging the status quo, Cytomegalovirus in transplantation challenging the status quo, pp.149-58, 2007. ,
DOI : 10.1111/j.1600-6143.2004.00571.x
Specific Inhibition of Human Cytomegalovirus Glycoprotein B-Mediated Fusion by a Novel Thiourea Small Molecule, Journal of Virology, vol.78, issue.3, pp.1289-1300, 2004. ,
DOI : 10.1128/JVI.78.3.1289-1300.2004
Potent and Selective Inhibition of Human Cytomegalovirus Replication by 1263W94, a Benzimidazole L-Riboside with a Unique Mode of Action, Antimicrobial Agents and Chemotherapy, vol.46, issue.8, 2002. ,
DOI : 10.1128/AAC.46.8.2365-2372.2002
Drug-resistant cytomegalovirus in transplant recipients: a French cohort study, J Antimicrob Chemother, vol.65, pp.2628-2640, 2010. ,
Phase I Dose Escalation Trial Evaluating the Pharmacokinetics, Anti-Human Cytomegalovirus (HCMV) Activity, and Safety of 1263W94 in Human Immunodeficiency Virus-Infected Men with Asymptomatic HCMV Shedding, Antimicrobial Agents and Chemotherapy, vol.46, issue.9, pp.2969-2976, 2002. ,
DOI : 10.1128/AAC.46.9.2969-2976.2002
Phase I Safety and Pharmacokinetic Trials of 1263W94, a Novel Oral Anti-Human Cytomegalovirus Agent, in Healthy and Human Immunodeficiency Virus-Infected Subjects, Antimicrobial Agents and Chemotherapy, vol.47, issue.4, pp.1334-1342, 2003. ,
DOI : 10.1128/AAC.47.4.1334-1342.2003
Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial, The Lancet Infectious Diseases, vol.11, issue.4, pp.284-292, 2011. ,
DOI : 10.1016/S1473-3099(11)70024-X
Antiviral activity of artesunate towards wild-type, recombinant, and ganciclovir-resistant human cytomegaloviruses, Journal of Molecular Medicine, vol.80, issue.4, pp.233-242, 2001. ,
DOI : 10.1007/s00109-001-0300-8
Evidence for clinical activity of artesunate in multidrug-resistant herpes simplex infection following HSCT, Bone Marrow Transplantation, vol.47, issue.11, pp.1482-1483, 2012. ,
DOI : 10.1016/S0140-6736(03)15162-8
Antiviral treatment of cytomegalovirus infection and resistant strains, Expert Opinion on Pharmacotherapy, vol.4, issue.2, pp.191-209, 2009. ,
DOI : 10.1159/000053979
Putative functional domains of human cytomegalovirus pUL56 involved in dimerization and benzimidazole D-ribonucleoside activity, Antivir Ther, vol.13, pp.643-654, 2008. ,
URL : https://hal.archives-ouvertes.fr/hal-00406828
The Novel Anticytomegalovirus Compound AIC246 (Letermovir) Inhibits Human Cytomegalovirus Replication through a Specific Antiviral Mechanism That Involves the Viral Terminase, Journal of Virology, vol.85, issue.20, pp.10884-10893, 2011. ,
DOI : 10.1128/JVI.05265-11
Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation, New England Journal of Medicine, vol.370, issue.19, pp.1781-1789, 2014. ,
DOI : 10.1056/NEJMoa1309533
First Pharmacokinetic and Safety Study in Humans of the Novel Lipid Antiviral Conjugate CMX001, a Broad-Spectrum Oral Drug Active against Double-Stranded DNA Viruses, Antimicrobial Agents and Chemotherapy, vol.56, issue.5, 2012. ,
DOI : 10.1128/AAC.05983-11
Alkoxyalkyl prodrugs of acyclic nucleoside phosphonates enhance oral antiviral activity and reduce toxicity: Current state of the art, Antiviral Research, vol.82, issue.2, pp.84-98, 2009. ,
DOI : 10.1016/j.antiviral.2009.01.005
Increased Antiviral Activity of 1-O-Hexadecyloxypropyl-[2-14C]cidofovir in MRC-5 Human Lung Fibroblasts Is Explained by Unique Cellular Uptake and Metabolism, Molecular Pharmacology, vol.63, issue.3, pp.678-681, 2003. ,
DOI : 10.1124/mol.63.3.678
Update on New Antivirals Under Development for the Treatment of Double-Stranded DNA Virus Infections, Clinical Pharmacology & Therapeutics, vol.5, issue.5, pp.610-619, 2010. ,
DOI : 10.1038/clpt.2010.178
Comparative Activities of Lipid Esters of Cidofovir and Cyclic Cidofovir against Replication of Herpesviruses In Vitro, Antimicrobial Agents and Chemotherapy, vol.49, issue.9, 2005. ,
DOI : 10.1128/AAC.49.9.3724-3733.2005
Alkoxyalkyl Esters of Cidofovir and Cyclic Cidofovir Exhibit Multiple-Log Enhancement of Antiviral Activity against Cytomegalovirus and Herpesvirus Replication In Vitro, Antimicrobial Agents and Chemotherapy, vol.46, issue.8, pp.2381-2386, 2002. ,
DOI : 10.1128/AAC.46.8.2381-2386.2002
The multispecific organic anion transporter (OAT) family, Pfl??gers Archiv - European Journal of Physiology, vol.440, issue.3, pp.337-50, 2000. ,
DOI : 10.1007/s004240000297
Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family, Xenobiotica, vol.280, issue.41, pp.778-801, 2008. ,
DOI : 10.1053/jhep.2002.34133
Polyspecific Organic Cation Transporters: Structure, Function, Physiological Roles, and Biopharmaceutical Implications, Pharmaceutical Research, vol.61, issue.7, pp.1227-51, 2007. ,
DOI : 10.1007/s11095-007-9254-z
Recent molecular advances in studies of the concentrative Na+-dependent nucleoside transporter (CNT) family: identification and characterization of novel human and mouse proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib), Molecular Membrane Biology, vol.18, issue.1, pp.65-72, 2001. ,
DOI : 10.1080/09687680010026313
A human transporter protein that mediates the final excretion step for toxic organic cations, Proceedings of the National Academy of Sciences, vol.102, issue.50, pp.17923-17931, 2005. ,
DOI : 10.1073/pnas.0506483102
Organic Cation Transporters (OCTs, MATEs), In Vitro and In Vivo Evidence for the Importance in Drug Therapy, Handb Exp Pharmacol, pp.105-67 ,
DOI : 10.1007/978-3-642-14541-4_3
The P-Glycoprotein Efflux Pump: How Does it Transport Drugs?, The Journal of Membrane Biology, vol.272, issue.1, pp.71-74, 1998. ,
DOI : 10.1007/s002329900448
Expression of adenosine triphosphate-binding cassette (ABC) drug transporters in peripheral blood cells: relevance for physiology and pharmacotherapy, 2007. ,
Ganciclovir permeation of the human erythrocyte membrane, Biochemical Pharmacology, vol.41, issue.2, pp.263-271, 1991. ,
DOI : 10.1016/0006-2952(91)90485-N
A RANDOMIZED PROSPECTIVE CONTROLLED TRIAL OF ORAL ACYCLOVIR VERSUS ORAL GANCICLOVIR FOR CYTOMEGALOVIRUS PROPHYLAXIS IN HIGH-RISK KIDNEY TRANSPLANT RECIPIENTS1, Transplantation, vol.66, issue.12, pp.1682-1688, 1998. ,
DOI : 10.1097/00007890-199812270-00019
Randomised comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipients, The Lancet, vol.346, issue.8967, pp.69-74, 1995. ,
DOI : 10.1016/S0140-6736(95)92110-9
Evaluation of ganciclovir for cytomegalovirus disease, DICP Ann Pharmacother, vol.23, pp.5-12, 1989. ,
Human pharmacokinetics of the antiviral drug DHPG, Clinical Pharmacology and Therapeutics, vol.40, issue.3, pp.281-286, 1986. ,
DOI : 10.1038/clpt.1986.177
Mechanism of ganciclovir uptake by rabbit retina and human retinal pigmented epithelium cell line ARPE-19, Current Eye Research, vol.17, issue.2, pp.127-136, 2004. ,
DOI : 10.1023/A:1015890516119
Transfer of antivirals across the human placenta, Early Human Development, vol.81, issue.8, pp.647-654, 2005. ,
DOI : 10.1016/j.earlhumdev.2005.02.002
The transfer of the nucleoside analog ganciclovir across the perfused human placenta, American Journal of Obstetrics and Gynecology, vol.170, issue.4, pp.967-972, 1994. ,
DOI : 10.1016/S0002-9378(94)70089-3
Polymorphism in the P-glycoprotein drug transporter MDR1 gene in renal transplant patients treated with cyclosporin A in a Polish population, Pharmacol Rep PR, vol.59, pp.199-205, 2007. ,
Amphiphilic Drug-Like Molecules Accumulate in a Membrane below the Head Group Region, The Journal of Physical Chemistry B, vol.118, issue.4, pp.1030-1039, 2014. ,
DOI : 10.1021/jp4112052
Risk Factors for Ganciclovir-Induced Thrombocytopenia and Leukopenia, Biological and Pharmaceutical Bulletin, vol.38, issue.2, pp.235-238, 2015. ,
DOI : 10.1248/bpb.b14-00588
A Controlled Trial of Ganciclovir to Prevent Cytomegalovirus Disease after Heart Transplantation, New England Journal of Medicine, vol.326, issue.18, pp.1182-1186, 1992. ,
DOI : 10.1056/NEJM199204303261803
Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients, The Lancet, vol.350, issue.9093, pp.1729-1733, 1997. ,
DOI : 10.1016/S0140-6736(97)05535-9
Ganciclovir, Drugs, vol.168, issue.7, pp.1153-1183, 2001. ,
DOI : 10.2165/00003495-200161080-00016
Population Pharmacokinetics of Ganciclovir in Solid-Organ Transplant Recipients Receiving Oral Valganciclovir, Antimicrobial Agents and Chemotherapy, vol.53, issue.7, pp.3017-3023, 2009. ,
DOI : 10.1128/AAC.00836-08
Transport of Cyclic Nucleotides and Estradiol 17-??-D-Glucuronide by Multidrug Resistance Protein 4: RESISTANCE TO 6-MERCAPTOPURINE AND 6-THIOGUANINE, Journal of Biological Chemistry, vol.276, issue.36, pp.33747-33754, 2001. ,
DOI : 10.1074/jbc.M104833200
MRP4: A previously unidentified factor in resistance to nucleosidebased antiviral drugs, Nature Medicine, vol.5, issue.9, pp.1048-1051, 1999. ,
DOI : 10.1038/12487
Pharmacogenetic Characteristics of Indinavir, Zidovudine, and Lamivudine Therapy in HIV-Infected Adults, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.42, issue.4, pp.441-449, 1999. ,
DOI : 10.1097/01.qai.0000225013.53568.69
Clinical and Genetic Determinants of Intracellular Tenofovir Diphosphate Concentrations in HIV-Infected Patients, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.47, issue.3, pp.298-303, 1999. ,
DOI : 10.1097/QAI.0b013e31815e7478
Polymorphisms in multidrug resistance-associated protein gene 4, 2009. ,
Variability in human hepatic MRP4 expression: influence of cholestasis and genotype, The Pharmacogenomics Journal, vol.47, issue.1, pp.42-52, 2007. ,
DOI : 10.1038/sj.tpj.6500451
MDR1 (ABCB1) G1199A (Ser400Asn) polymorphism alters transepithelial permeability and sensitivity to anticancer agents, Cancer Chemotherapy and Pharmacology, vol.18, issue.1, pp.183-188, 2009. ,
DOI : 10.1007/s00280-008-0906-4
ABCB1 G1199A Polymorphism and Ovarian Cancer Response to Paclitaxel, Journal of Pharmaceutical Sciences, vol.97, issue.6, pp.2045-2048, 2008. ,
DOI : 10.1002/jps.21169
Association of ABCB1 polymorphisms with survival and in vitro cytotoxicty in de novo acute myeloid leukemia with normal karyotype, The Pharmacogenomics Journal, vol.65, issue.2, pp.111-118, 2012. ,
DOI : 10.1038/tpj.2010.79
Genetic polymorphisms of the adenosine triphosphate-binding cassette transporters (ABCG2, ABCB1) and gefitinib toxicity, Nagoya J Med Sci, vol.74, pp.133-140, 2012. ,
Impact of ABCG2 polymorphisms on the clinical outcome of TKIs therapy in Chinese advanced nonsmall-cell lung cancer patients, Cancer Cell Int, vol.15, 2015. ,
ABCB1 Variation and Treatment Response in AIDS Patients: Initial Results of the Henan Cohort, PLoS ONE, vol.19, issue.1, p.55197, 2013. ,
DOI : 10.1371/journal.pone.0055197.s002
Association of enzyme and transporter genotypes with the pharmacokinetics of imatinib, Clinical Pharmacology & Therapeutics, vol.80, issue.2, pp.192-201, 2006. ,
DOI : 10.1016/j.clpt.2006.05.003
OCT1 genetic variants are associated with long term outcomes in imatinib treated chronic myeloid leukemia patients, European Journal of Haematology, vol.83, issue.4, pp.283-288, 2014. ,
DOI : 10.1111/ejh.12235
Identification and Characterization of Proximal Promoter Polymorphisms in the Human Concentrative Nucleoside Transporter 2 (SLC28A2), Journal of Pharmacology and Experimental Therapeutics, vol.328, issue.3, pp.699-707, 2009. ,
DOI : 10.1124/jpet.108.147207
Role of nucleoside transporters SLC28A2/3 and SLC29A1/2 genetics in ribavirin therapy, Pharmacogenetics and Genomics, vol.21, issue.5, pp.289-296, 2011. ,
DOI : 10.1097/FPC.0b013e32834412e7
Impact of Solute Carrier Family 29 Member 1 (SLC29A1) Single Nucleotide Polymorphisms on mRNA Expression in Peripheral Blood Mononuclear Cells, Biological and Pharmaceutical Bulletin, vol.36, pp.144-146, 2013. ,
DOI : 10.1248/bpb.b12-00809
P-glycoprotein: Tissue Distribution, Substrates, and Functional Consequences of Genetic Variations, Handb Exp Pharmacol, pp.261-283, 2011. ,
DOI : 10.1007/978-3-642-14541-4_6
Combination gene therapy using multidrug resistance (MDR1) gene shRNA and herpes simplex virus-thymidine kinase, Cancer Letters, vol.261, issue.2, pp.205-214, 2008. ,
DOI : 10.1016/j.canlet.2007.11.011
Hematopoietic stem cell differentiation affects expression and function of MRP4 (ABCC4), a transport protein for signaling molecules and drugs, International Journal of Cancer, vol.89, issue.Part 2, pp.2303-2311, 2009. ,
DOI : 10.1002/ijc.24207
Breast Cancer Resistance Protein (BCRP/ABCG2) Induces Cellular Resistance to HIV-1 Nucleoside Reverse Transcriptase Inhibitors, Molecular Pharmacology, vol.63, issue.1, pp.65-72, 2003. ,
DOI : 10.1124/mol.63.1.65
Human Organic Anion Transporters and Human Organic Cation Transporters Mediate Renal Antiviral Transport, Journal of Pharmacology and Experimental Therapeutics, vol.300, issue.3, pp.918-924, 2002. ,
DOI : 10.1124/jpet.300.3.918
Molecular Determinants of Specificity for Synthetic Nucleoside Analogs in the Concentrative Nucleoside Transporter, CNT2, Journal of Biological Chemistry, vol.281, issue.36, pp.26675-26682, 2006. ,
DOI : 10.1074/jbc.M513421200
Conditional overexpression of Stat3?? in differentiating myeloid cells results in neutrophil expansion and induces a distinct, antiapoptotic and pro-oncogenic gene expression pattern, Journal of Leukocyte Biology, vol.82, issue.4, pp.975-985, 2007. ,
DOI : 10.1189/jlb.1206766
An adaptive grid nonparametric approach to pharmacokinetic and dynamic (PK/PD) population models, Fourteenth Ieee Symposium on Computer-Based Medical Systems, Proceedings. Ieee Computer Soc, pp.389-394, 2001. ,
Two general methods for population pharmacokinetic modeling: non-parametric adaptive grid and non-parametric Bayesian, Journal of Pharmacokinetics and Pharmacodynamics, vol.21, issue.4, pp.189-199, 2013. ,
DOI : 10.1007/s10928-013-9302-8
Information Theory and an Extension of the Maximum Likelihood Principle, pp.199-213, 1998. ,